Hvsen Biotechnology Co., Ltd. (300871.SZ)
CNY 26.01
(-11.08%)
CNY 26.01
(-11.08%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 228.67 Million CNY | 14.91% |
| 2022 | 199 Million CNY | -14.05% |
| 2021 | 231.55 Million CNY | 81.94% |
| 2020 | 127.26 Million CNY | 75.75% |
| 2019 | 72.41 Million CNY | -11.99% |
| 2018 | 82.27 Million CNY | 42.1% |
| 2017 | 57.9 Million CNY | 20.73% |
| 2016 | 47.96 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 251.24 Million CNY | -13.05% |
| 2024 Q1 | 278.95 Million CNY | 21.99% |
| 2024 Q2 | 288.95 Million CNY | 3.58% |
| 2023 Q1 | 217.5 Million CNY | 9.3% |
| 2023 FY | 228.67 Million CNY | 14.91% |
| 2023 Q4 | 228.67 Million CNY | -3.76% |
| 2023 Q3 | 237.61 Million CNY | -4.78% |
| 2023 Q2 | 249.54 Million CNY | 14.73% |
| 2022 Q4 | 199 Million CNY | 11.01% |
| 2022 Q3 | 179.26 Million CNY | -19.78% |
| 2022 Q2 | 223.47 Million CNY | 10.65% |
| 2022 Q1 | 201.96 Million CNY | -12.78% |
| 2022 FY | 199 Million CNY | -14.05% |
| 2021 Q2 | 232.77 Million CNY | 30.33% |
| 2021 Q1 | 178.6 Million CNY | 40.34% |
| 2021 Q3 | 211.79 Million CNY | -9.01% |
| 2021 Q4 | 231.55 Million CNY | 9.33% |
| 2021 FY | 231.55 Million CNY | 81.94% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 FY | 127.26 Million CNY | 75.75% |
| 2020 Q4 | 127.26 Million CNY | 25.58% |
| 2020 Q3 | 101.34 Million CNY | 2.37% |
| 2020 Q2 | 99 Million CNY | 0.0% |
| 2019 Q2 | 96.01 Million CNY | 0.0% |
| 2019 Q4 | 72.41 Million CNY | 0.0% |
| 2019 FY | 72.41 Million CNY | -11.99% |
| 2018 FY | 82.27 Million CNY | 42.1% |
| 2017 FY | 57.9 Million CNY | 20.73% |
| 2016 FY | 47.96 Million CNY | 0.0% |